Rana McKay, MD, Dana-Farber, presents Impact of Aspirin and Non-Aspirin NSAIDs on Outcomes in Metastatic RCC at the 2016 annual…
Browsing: Acute Lymphoblastic Leukemia
Aly-Khan A. Lalani, Department of Medical Oncology, Cross Cancer Institute, University of Alberta presents Proton Pump Inhibitors and Survival Outcomes…
Chung-Han Lee, MD, PhD, Medical Oncologist, Memorial Sloan Kettering presents Medullary Renal Cell Carcinoma (RCC): Genomics and Treatment Outcomes at…
Maria Becerra, Research Fellow at Memorial Sloan Kettering Cancer Center presents Characterization of genomic alterations associated with metastatic tropism in…
Thomas Hutson, Memorial Sloan Kettering Cancer Center, New York, NY presents A randomized phase 2 trial of CRLX101 in combination…
Rana McKay, MD, Assistant Professor of Medicine, HMS/DFCI/BWH presents PD-1/PD-L1 Blockage in Non-Clear Cell RCC at the 2016 annual International…
Toni K. Choueiri Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute presents Savolitinib (volitinib, AZD6094, HMPL-504): Future Directions at the…
Primo N. Lara, Jr., MD, Professor of Medicine, University of California Davis School of Medicine, Acting Director, UC Davis Comprehensive…
Laurence Albiges, MD, Gustave Roussy presents Crizotinib In Papillary RCC at the 2016 annual International Kidney Cancer Symposium.
Brian Shuch, MD, Assistant Professor of Urology/Radiology, Yale School of Medicine presents Developments in Biology of Non-Clear Cell RCC at…
Debate: Kidney Cancer: Should we explore drug combination strategies in an adjuvant setting?
Priti S. Hegde, PhD, Director, CI Franchise Lead, Biomarkers Genentech Roche presents Blocking VEGF in addition to checkpoint inhibition in…
Paula Ragan, CEO, X4 Pharmaceuticals presents Addressing Unmet Need in ccRCC Through Targeted CXCR4 Blockade at the 2016 annual International…
Christopher Turner, MD, Vice President, Clinical Science presents Novel RCC Targets from Immuno-Oncology and Antibody-Drug Conjugates at the 2016 annual…
Ian M. Waxman, MD, Bristol-Myers Squibb presents New opportunities for immuno-oncology in renal cell carcinoma at the 2016 annual International…
Moderator Michael B. Atkins , Georgetown-Lombardi Comprehensive Cancer Center participates in a debate: In 2020 Which Approach do you predict…
Neeraj Agarwal, MD, Associate Professor of Medicine Director, GU Medical Oncology, Huntsman Cancer Institute presents Toxicities with PD-1 Inhibitors: The…
Tian Zhang, MD, Duke Cancer Institute, Duke University Medical Center presents “Vaccines in Renal Cell Carcinoma: A Lost Cause or…
Guru Sonpavde, MD, Associate Professor of Medicine Director, Urologic Oncology, UAB Comprehensive Cancer Center presents Sequencing VEGF and PD-1 Inhibition…
Hans Hammers MD, PhD, Kidney Cancer Program, UT Southwestern presents PD1 and CTLA4 Inhibition in RCC at the 2016 annual…
David McDermott, MD, Leader, Kidney Cancer Program Dana-Farber/Harvard Cancer Center presents To Combine: VEGF + PD-1 at the 2016 annual…
Charles G. Drake MD / PhD, Director GU Medical Oncology, Co-Director Immunotherapy Program, Associate Director for Clinical Research, Herbert Irving…
Robert G. Uzzo, M.D.Willing G. Pepper Chairman of Surgery Fox Chase Cancer Center, Temple University School of Medicine Chair, Department…
Mohamad E. Allaf, MD, Associate Professor of Urology, Oncology, & BME MEA Endowed Director, Minimally Invasive Surgery Johns Hopkins Medicine…
Sumanta K. Pal, MD, City of Hope Comprehensive Cancer Center presents Atezolizumab Adjuvant Study: Medical Oncologist Perspective at the 2016…
Lauren C. Harshman MD, Assistant Professor of Medicine, Harvard Medical School, Dana-Farber, presents a strong case for a neoadjuvant/adjvuant approach…
Naomi B. Haas, MD, Director, Prostate and Kidney Cancer Program, Associate Professor of Medicine at the Hospital of the University…
Bradley C. Leibovich, MD, FACS, Chair, Department of Urology, David C. Utz Professor of Urology, Mayo Clinic, Rochester, MN presents…
Jose A. Karam, MD, FACS, Assistant Professor, Department of Urology, MD Anderson asks “Cytoreductive Nephrectomy: Yes, No, Clinical Trial?” at…
R. Houston Thompson, MD, Professor of Urology, Mayo Clinic presents Cytoreductive Nephrectomy: Optimizing Surgical Outcomes and Minimizing Complications at the…
E. Jason Abel, MD, FACS, Associate Professor, Department of Urology, University of Wisconsin presents Cytoreductive nephrectomy in locally advanced renal…
Viraj Master MD PhD FACS, Professor Associate Chair for Clinical Affairs and Quality, Director of Clinical Research Unit Department of…
Ithaar H. Derweesh, M.D., University of California, San Diego asks the question “Neoadjuvant Therapy: Where are we in 2016?” at…
Kamran Ahrar, MD, MBA, Professor, Interventional Radiology presents Renal Tumor Ablation: Current Technologies and Outcomes at the 2016 annual International…
Phillip M. Pierorazio, MD, Assistant Professor of Urology and Oncology, Brady Urological Institute, Sidney Kimmel Cancer Center, Johns Hopkins Hospital,…
Alexander Kutikov, MD, FACS, Associate Professor of Urologic Oncology Fox Chase Cancer Center, Philadelphia, PA presents “Renal Biopsy: Always, Sometimes…
Brandon Manley presents Characterizing Recurrent And Lethal Small Renal Masses In Clear Cell Renal Cell Carcinoma Using Recurrent Somatic Mutations…
Dr. Nicholas G. Cost, M.D. Assistant Professor, Department of Surgery, Division of Urology University of Colorado Cancer Center presents RCC…
Dr. Karim Touijer, MD, MPH. Memorial Sloan-Kettering Cancer Center presents Surgery for cT1b RCC: Partial Nephrectomy, Radical nephrectomy, Clinical Trial?…
Dr. Daniel Heng MD MPH FRCPC of Tom Baker Cancer Center, University of Calgary @DrDanielHeng presents Renal cell carcinoma prognostication…
Dr. Sima Porten, MD MPH, Assistant Professor, Department of Urology UCSF presents Partial Nephrectomy 2016, Techniques, Outcomes, and Selection at…
Dr. Jamil Syed BS Research Fellow of Yale Department of Urology presents The Incidence and Predictive Factors of Metachronous Bilateral…
Is stem cell transplant (SCT) a viable option for MPN patients? Noted MPN specialist and researcher, Dr. David Snyder from…
Stephan Stilgenbauer, MD, PhD of Ulm University, Ulm, Germany, talks about individualized treatment and delivering the right treatment for the…
Barbara Eichhorst, MD of the University of Cologne, Cologne, Germany, discusses how sharing data between groups on cancer can help…
Arnon Kater, MD, PhD of the Academic Medical Center, Amsterdam, Netherlands talks about how to overcome mental health issues that…
Jennifer Woyach, MD of The Ohio State University Comprehensive Cancer Center, Columbus, OH talks developments in chronic lymphocytic leukaemia (CLL)…
Jasmin Bahlo, PhD of University of Cologne, Cologne, Germany talks about the analysis of the projects that are underway at…
Barbara Eichhorst, MD of the University of Cologne, Cologne, Germany, discusses how best to deal with Richters transformation. Dr Eichhorst…
Federico Caligris-Cappio, MD of Università Vita-Salute San Raffaele, Milan, Italy, talks about new treatment and traditional treatment options for chronic…